Perspective Therapeutics (CATX) 10-Q2022 Q3 Quarterly report

Filed: 12 May 22, 7:18pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: adjusted, affiliate, armed, bank, banking, banned, Belarusian, blocking, Camino, Canada, commodity, conflict, consignee, counsel, Crimea, currency, Donetsk, El, entirety, espionage, Europe, European, evolving, experienced, export, Foreseeable, forward, Germany, GmbH, imposition, inability, instability, Interbank, Japan, Kingdom, largest, length, Luhansk, magnify, military, nonprovisional, outcome, outflow, People, political, posted, President, Quarterly, rapidly, recognition, region, Republic, restricting, retained, retaliation, retaliatory, sanction, sanctioned, separatist, social, SphereRx, stabilize, superseded, Switzerland, Telecommunication, trade, turn, Ukraine, Union, unknown, unpredictable, waned, wire, Worldwide, written

Removed: arrangement, postponed, provisional, shut

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated CATX transcripts

CATX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.2

Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

Addendum No. 6 dated 04.05.2022

Contract № 840/08625142/31/22-21

THE SELLER

Isotope - Regional Alliance, Joint-Stock Company (Isotope JSC)

Pogodinskaya str., 22,

Moscow, 119435, Russia.

Phone: +7 (495) 981-96-16/17

THE BUYER

The Company IsoRay Medical Inc.

350 Hills Street, Suite 106

Richland, WA 99354-5411 USA

THE BUYER and THE SELLER have mutually agreed on the following:

Paying party for the shipments under the current contract could be:

SphereRx, LLC

Chase Bank

Bank Code Type: ABA 325070760

Bank Code Type: Swift CHASUS33

Account: [**]

Account Name: SphereRx

All other terms and conditions are in accordance with Contract No. 840/08625142/31/22-21, Addendum 1-5.

The present Addendum No.6 is an integral part of the Contract and may be signed via facsimile or e-mail.

/s/ Konstantin Ershov, Head of Supplies, May 5, 2022

THE SELLER

/s/ Jonathan Hunt, CFO, May 5, 2022

THE BUYER

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.